elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26751226-BB011093-0448-4167-A5DD-08A81653417D
Q26751226-BB011093-0448-4167-A5DD-08A81653417D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26751226-BB011093-0448-4167-A5DD-08A81653417D
Antiangiogenic mechanisms and factors in breast cancer treatment
P2860
Q26751226-BB011093-0448-4167-A5DD-08A81653417D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26751226-BB011093-0448-4167-A5DD-08A81653417D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9942dbb4a06ea7a52db8738f6315fdad5f0279dc
P2860
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer